Group One Trading’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-70,700
Closed -$5.3M 5588
2015
Q3
$5.3M Buy
70,700
+8,300
+13% +$620K 0.07% 335
2015
Q2
$4.7M Buy
62,400
+23,200
+59% +$1.24M 0.07% 356
2015
Q1
$1.97M Buy
39,200
+32,100
+452% +$1.35M 0.03% 652
2014
Q4
$246K Buy
7,100
+2,100
+42% +$73.3K ﹤0.01% 2133
2014
Q3
$164K Buy
+5,000
New +$176K ﹤0.01% 2541
2014
Q2
Sell
-800
Closed -$32K 5804
2014
Q1
$32K Buy
+800
New +$35.8K ﹤0.01% 3960

Group One Trading's KYTH Position: Q4 2015 in Review

Group One Trading sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 7,719 shares — an estimated $579K sold.

Group One Trading first reported a position in KYTH in Q2 2014 and held it in 5 quarters. The position peaked at $579K in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Group One Trading reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Group One Trading sold 7,719 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $579K.
  • Group One Trading first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2014 and held it in 5 quarters.
  • Group One Trading's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $579K in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Group One Trading's 13F filing for Q4 2015, filed 11 Feb 2016.